NCT05690724 - Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

September 18, 2024

Conditions

Mild Cognitive Impairment

Interventions

DIETARY_SUPPLEMENT

Mitocholine™ or Placebo

Participants will be instructed to consume one bottle of study product daily for the duration of the trial (16 weeks). They will be instructed to consume the product in the morning with breakfast.

Trial Locations (1)

T23R50R

RECRUITING

Atlantia Clinical Trials, Cork